Exosomes from miR-374a-5p-modified mesenchymal stem cells inhibit the progression of renal fibrosis by regulating MAPK6/MK5/YAP axis

Webster AC, Nagler EV, Morton RL, et al. Chronic kidney disease. Vol. 389. (London England): Lancet; 2017. p. 1238–1252.

10.1038/nrneph.2016.163

Hercz D, 2020, Cochrane Database Syst Rev, 12, Cd011393

10.1038/s41586-020-2941-1

10.1016/j.diff.2016.05.008

10.21873/invivo.11019

10.1007/978-981-13-8871-2_2

10.3892/mmr.2017.7692

10.2741/4823

10.1093/toxsci/kfy159

10.2174/2211536607666180827111633

10.1002/jcp.27486

10.1080/15476286.2019.1667215

10.1155/2016/8319283

10.1152/physiolgenomics.00039.2017

10.1152/ajprenal.00429.2016

10.3389/fimmu.2019.01464

10.1016/j.ceb.2009.03.007

10.1016/j.pharmthera.2017.02.020

10.1080/21655979.2021.2001185

10.1080/21655979.2021.2012402

10.1038/mt.2016.90

10.1016/j.ymthe.2019.01.008

10.18632/oncotarget.14831

10.1080/21655979.2021.2001912

10.1080/21655979.2021.1972900

10.1080/21655979.2021.1984002

10.1080/21655979.2021.2004981

10.1080/21655979.2021.1995580

Dong H, 2021, Bioeng, 12, 9693

Shen C, 2021, Bioeng, 13, 27

Wang B, 2021, Bioeng, 12, 12040

10.1016/j.jsbmb.2018.04.008

10.1186/s13045-015-0220-7

Shang J, 2020, Bioeng, 11, 547

Meng X, 2021, Bioeng, 12, 11610

10.1590/1414-431x20198735

10.7150/thno.43315

10.1007/s13577-021-00617-w

10.1016/j.gene.2020.144661

10.1042/BJ20110035

10.1038/s41418-019-0349-y

10.1016/j.cca.2019.02.021

10.1152/ajpheart.00532.2017

10.1158/0008-5472.CAN-19-1339